Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results

2013/04/06 by Alan H.B. Wu, Frank Wians, Frank H. Wians +2 · 25 citations
Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · #IL-33, ST2, and ILC Pathways #Galectins and Cancer Biology #Studies on Chitinases and Chitosanases

paper · doi:10.1016/j.ahj.2013.02.029

Cited by

• Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure. [europepmc]
• Serial galectin-3 and future cardiovascular disease in the general population. [europepmc]
• Biomarkers in heart failure: the importance of inconvenient details. [europepmc]
• Traditional Chinese medicine baoxin decoction improves cardiac fibrosis of rats with dilated cardiomyopathy. [europepmc]
• Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients. [europepmc]
• Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). [europepmc]
• The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium. [europepmc]
• Predictive value of soluble ST2 in adolescent and adult patients with complex congenital heart disease. [europepmc]
• Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes. [europepmc]
• Prognostic value of soluble ST2 in adults with congenital heart disease. [europepmc]
• Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome-There is Meat on the Bone. [europepmc]
• Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis. [europepmc]
• Biological variation of cardiac markers in patients with aortic valve stenosis. [europepmc]
• Multimarker approach including CRP, sST2 and GDF-15 for prognostic stratification in stable heart failure. [europepmc]
• Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure. [europepmc]
• Development of a Novel Homogeneous Nanoparticle-Based Assay for Rapid and High-Throughput Quantitation of the sST2 Protein in Human Serum. [europepmc]
• Soluble ST2 and mixed venous oxygen saturation for prediction of mortality in patients with pulmonary hypertension. [europepmc]
• Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis. [europepmc]
• Exploring the Causal Effects of Circulating ST2 and Galectin-3 on Heart Failure Risk: A Mendelian Randomization Study. [europepmc]
• Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease. [europepmc]
• The prognostic role of galectin-3 and endothelial function in patients with heart failure. [europepmc]
• Impact of Myocardial Ischemia and Revascularization by Percutaneous Coronary Intervention on Circulating Level of Soluble ST2. [europepmc]
• Association of soluble suppression of tumorigenicity 2 with mortality and adverse outcomes in chronic kidney disease: a systematic review and meta-analysis. [europepmc]
• Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study. [europepmc]
• Natriuretic Peptides and Soluble ST2 Improve Echocardiographic and Invasive Long-Term Survival Prediction in Patients Evaluated for Diastolic Dysfunction. [europepmc]